TRADE WITH CONVICTION

Friday, July 3, 2026
RSS



IPO

Lime's $1.7 Billion IPO: A Sign of Renewed Market Confidence?

Lime's $1.7 billion IPO highlights a resurgence in market enthusiasm for new public offerings.

Catherine Walsh • Jul 2, 2026
IPO

OpenPayd's SPAC Merger: A New Chapter for Fintech

OpenPayd's SPAC merger with Titan Acquisition Corp. signals a promising future for fintech. Here's what investors need to know.

Catherine Walsh • Jun 30, 2026
IPO

Onex Partners Expands Portfolio with AirSprint Acquisition: Implications for Private Aviation

Onex Partners' acquisition of AirSprint signals growth potential in private aviation and highlights market consolidation trends.

Catherine Walsh • Jun 25, 2026
IPO

Cboe Global Markets Launches Prediction Markets: A New Frontier in Trading

Cboe's new prediction markets could reshape trading dynamics and offer fresh opportunities for traders.

Sarah Chen • Jun 24, 2026
IPO

Boundless Bio and Serapha Bio Merger: Implications for Biotech Investors

The merger of Boundless Bio and Serapha Bio, backed by a $230M placement, signals growth potential in biotech.

Catherine Walsh • Jun 23, 2026
IPO

SpaceX Taps Bond Markets Days After Record IPO, Sits on $100.8B Cash Fortress

SpaceX launches senior unsecured notes offering post-IPO while disclosing massive cash reserves. KeyBanc initiates coverage with Hold rating…

Catherine Walsh • Jun 22, 2026
IPO

California's IPO Tax Expectations: A Double-Edged Sword

California anticipates a tax windfall from tech IPOs, but uncertainties loom over revenue sustainability.

Marcus Rivera • Jun 18, 2026
IPO

Copley Acquisition Corp's Game-Changing SPAC Merger with Ignite Proteomics

Copley Acquisition Corp's SPAC merger with Ignite Proteomics could reshape the oncology diagnostics landscape.

Marcus Rivera • Jun 11, 2026
IPO

Copley Acquisition Corp's $1B Merger: A New Frontier in Precision Oncology

Copley Acquisition Corp's merger with Ignite Proteomics could reshape precision oncology investment opportunities.

Sarah Chen • Jun 11, 2026
IPO

Lisata Therapeutics' Tender Offer: What It Means for Investors

Kuva Labs proposes a tender offer for Lisata Therapeutics, potentially valuing shares at $7.00 each. What does this mean for investors?

Marcus Rivera • Jun 10, 2026
IPO

Canfor Expands Market Reach with PinkWood Acquisition

Canfor's $68 million acquisition of PinkWood's I-joist business enhances its portfolio and positions it for growth in the Canadian construct…

Sarah Chen • Jun 10, 2026
IPO

Payoneer Global's Stock Surge: What a $2.7B Acquisition Could Mean

Nuvei's potential $2.7 billion acquisition of Payoneer could reshape the fintech landscape, impacting investor sentiment and market dynamics…

Sarah Chen • Jun 9, 2026